Mogy Joel R Investment Counsel’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-15,276
Closed -$3.13M 123
2017
Q3
$3.13M Hold
15,276
0.52% 44
2017
Q2
$3.71M Sell
15,276
-155
-1% -$36.4K 0.64% 41
2017
Q1
$3.69M Sell
15,431
-872
-5% -$203K 0.64% 41
2016
Q4
$3.42M Sell
16,303
-5,693
-26% -$1.18M 0.62% 44
2016
Q3
$5.07M Sell
21,996
-422
-2% -$103K 0.93% 33
2016
Q2
$5.18M Sell
22,418
-22
-0.1% -$5.07K 0.96% 36
2016
Q1
$6.01M Buy
22,440
+20,325
+961% +$5.82M 1.12% 34
2015
Q4
$6.61K Sell
2,115
-15,646
-88% -$4.66M 1.24% 32
2015
Q3
$4.83M Buy
17,761
+4,579
+35% +$1.41M 0.95% 34
2015
Q2
$4M Buy
13,182
+2,564
+24% +$765K 0.76% 41
2015
Q1
$3.16M Buy
+10,618
New +$3.03M 0.59% 52

Other funds holding AGN

Mogy Joel R Investment Counsel's AGN Position: Q4 2017 in Review

Mogy Joel R Investment Counsel sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 15,276 shares — an estimated $3.13M sold.

Mogy Joel R Investment Counsel first reported a position in AGN in Q1 2015 and held it in 11 quarters. The position peaked at $6.01M in Q1 2016. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Mogy Joel R Investment Counsel reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Mogy Joel R Investment Counsel sold 15,276 Allergan plc shares in Q4 2017, an estimated $3.13M.
  • Mogy Joel R Investment Counsel first reported a position in Allergan plc in Q1 2015 and held it in 11 quarters.
  • Mogy Joel R Investment Counsel's Allergan plc position peaked at $6.01M in Q1 2016.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Mogy Joel R Investment Counsel's 13F filing for Q4 2017, filed 7 Feb 2018.